We describe a new class of NO-donor hypoglycemic products obtained by joining tolbutamide, a typical hypoglycemic sulfonylurea, with a NO-donor moiety through a hard link. As NO-donors we chose either furoxan (1,2,5-oxadiazole 2-oxide) derivatives or the classical nitrooxy function. A preliminary biological characterization of these compounds, including stimulation of insulin release from cultured rat pancreatic b-cells and in vitro vasodilator and anti-aggregatory activities, is reported.
Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues.
LAZZARATO, Loretta;MARINI, Elisabetta;GUGLIELMO, Stefano;FRUTTERO, Roberta;GASCO, Alberto
2012-01-01
Abstract
We describe a new class of NO-donor hypoglycemic products obtained by joining tolbutamide, a typical hypoglycemic sulfonylurea, with a NO-donor moiety through a hard link. As NO-donors we chose either furoxan (1,2,5-oxadiazole 2-oxide) derivatives or the classical nitrooxy function. A preliminary biological characterization of these compounds, including stimulation of insulin release from cultured rat pancreatic b-cells and in vitro vasodilator and anti-aggregatory activities, is reported.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
tolbutamide.pdf
Open Access dal 01/07/2014
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
457.5 kB
Formato
Adobe PDF
|
457.5 kB | Adobe PDF | Visualizza/Apri |
|
2012_tolbutamide_BMCL.pdf
Accesso riservato
Descrizione: PDF editoriale
Tipo di file:
PDF EDITORIALE
Dimensione
244.75 kB
Formato
Adobe PDF
|
244.75 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
